IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Nov 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-11-12

Reporting Person: MCKEON BRIAN P (Executive VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-12	Common Stock	M	9225	$67.85	Acquired	35541.6426	Direct
2021-11-12	Common Stock	S	6952	$620.5498	Disposed	28589.6426	Direct
2021-11-12	Common Stock	S	2273	$621.2609	Disposed	26316.6426	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-12	Non-Qualified Stock Option (right-to-buy)	$67.85	M	9225	Disposed	2026-02-13	Common Stock (9225)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18050	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $620.00 to $621.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $621.045 to $621.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017.

F4: Not applicable.